让食物成为你的药物 - 食纤维
Mengqi Liu1, Shouren Li1, Shixi Cao1
1College of Animal Science and Technology, Henan Agricultural University, Zhengzhou, China. annysyh@henau.edu.cn.
Food & function
|July 10, 2024
概括
食纤维 (DF) 对人类健康至关重要,影响肠道微生物群和疾病预防. 了解DF,肠道微生物和健康之间的复杂相互作用对于营养指导至关重要.
科学领域:
- 营养科学 营养科学
- 微生物学 微生物学
- 胃肠病学 胃肠病学
背景情况:
- 食纤维 (DF) 在营养研究中历来被忽视.
- 新出现的证据凸显了DF在人类健康和发展方面的重要作用.
- 关于食物作为药物的古老智慧越来越多地得到科学发现的支持.
研究的目的:
- 探索食纤维和肠道微生物群之间的复杂关系.
- 阐明食纤维,肠道微生物群和相关疾病之间的联系.
- 为涉及食纤维的疾病风险降低策略提供科学基础.
主要方法:
- 对饮食纤维摄入量和健康结果的流行病学研究的审查.
- 对肠道微生物群的组成和功能研究的分析.
- 综合有关食纤维,肠道微生物群和宿主生理学的相互作用的当前知识.
主要成果:
- 饮食纤维摄入量,特别是全谷物,豆类,水果和蔬菜的摄入量,与肠道微生物群调节有关.
- 多种食纤维和特定的肠道微生物之间的相互作用是复杂的,并影响健康.
- 有证据表明,食纤维在通过肠道微生物群调节来预防各种疾病方面起着重要作用.
结论:
- 食纤维是肠道微生物群组成和功能的关键决定因素.
- 向饮食纤维摄入量可以成为管理肠道微生物群相关疾病的策略.
- 对食纤维与微生物群相互作用的具体机制进行进一步的研究是有必要的,以实现个性化的营养和疾病预防.
相关概念视频
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
331
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
331
Irritable Bowel Syndrome III: Medical and Nursing Management
190
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
190
Drugs for Treatment of Constipation-Predominant IBS
154
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
154
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents
203
Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...
Adsorbents...
203
Cancer Prevention
6.1K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.1K
Drugs for Treatment of Diarrhea-Predominant IBS
156
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
156


